Verastem, Inc. (VSTM) stock
VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.41−0.29 (-3.77%)
Close on Nov 17, 2026Market cap $671.08MP/E –Yield –
Verastem price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Verastem's price to sales ratio was 9.4× on Nov 11, 2026, against 56.9× a year earlier. Over the last 5 years it ranged from 3.6× to 241.5×, with a median of 13.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 9.4× | −48.7 |
| 2025 | Oct 31, 2025 | 58.1× | +28.0 |
| 2023 | Apr 28, 2023 | 30.2× | +3.4 |
| 2022 | Dec 30, 2022 | 26.8× | −158.7 |
| 2021 | Dec 31, 2021 | 185.4× | +181.5 |
| 2020 | Dec 31, 2020 | 3.9× | −2.7 |
| 2019 | Dec 31, 2019 | 6.6× | – |
See a number that looks wrong?